JTCVS Open (Sep 2020)

Commentary: Epsilon-aminocaproic acid versus tranexamic acid, the David and Goliath of antifibrinolyticsCentral Message

  • David Faraoni, MD, PhD, FAHA

DOI
https://doi.org/10.1016/j.xjon.2020.05.011
Journal volume & issue
Vol. 3
pp. 126 – 127

Abstract

Read online

No abstracts available.